SCHEMBL5607663

SCHEMBL5607663

COC(=Cc1ccc(OCC(C)O)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MTNR1A P48039 3/20 0.39
MTNR1B P49286 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
TSHR P16473 2/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CNR1 P21554 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
GAA P10253 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607661 1.00 LMNA (0.50) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5606925 0.87 PTGS2 (0.39) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5606920 0.87 PTGS2 (0.39) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5607375 0.87 MTNR1A (0.38) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5606854 0.87 MTNR1A (0.38) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5606850 0.87 MTNR1A (0.38) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5607379 0.87 MTNR1A (0.38) LMNAPOLBMAPTNPSR1MTNR1A
SCHEMBL5606675 0.79 GAA (0.46) MAPTABCG2GAA
SCHEMBL5606676 0.79 GAA (0.46) MAPTABCG2GAA
SCHEMBL5607238 0.78 MAPT (0.41) MAPTABCG2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR LMNA 1420/4885POLB 2813/4885MAPT 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.